image
Healthcare - Medical - Devices - NYSE - US
$ 390.08
1.77 %
$ 149 B
Market Cap
41.9
P/E
1. INTRINSIC VALUE

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties.[ Read More ]

The intrinsic value of one SYK stock under the base case scenario is HIDDEN Compared to the current market price of 390 USD, Stryker Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SYK

image
FINANCIALS
20.5 B REVENUE
11.11%
3.89 B OPERATING INCOME
36.85%
3.16 B NET INCOME
34.22%
3.71 B OPERATING CASH FLOW
41.43%
-962 M INVESTING CASH FLOW
67.10%
-1.59 B FINANCING CASH FLOW
-112.82%
5.49 B REVENUE
1.33%
1.08 B OPERATING INCOME
-6.30%
834 M NET INCOME
1.09%
1.47 B OPERATING CASH FLOW
132.86%
-2.17 B INVESTING CASH FLOW
-1756.41%
2.65 B FINANCING CASH FLOW
374.64%
Balance Sheet Decomposition Stryker Corporation
image
Current Assets 12.5 B
Cash & Short-Term Investments 3.05 B
Receivables 3.76 B
Other Current Assets 5.7 B
Non-Current Assets 27.4 B
Long-Term Investments 0
PP&E 3.22 B
Other Non-Current Assets 24.2 B
Current Liabilities 7.92 B
Accounts Payable 1.52 B
Short-Term Debt 2.24 B
Other Current Liabilities 4.17 B
Non-Current Liabilities 13.4 B
Long-Term Debt 11.3 B
Other Non-Current Liabilities 2.14 B
EFFICIENCY
Earnings Waterfall Stryker Corporation
image
Revenue 20.5 B
Cost Of Revenue 7.44 B
Gross Profit 13.1 B
Operating Expenses 9.21 B
Operating Income 3.89 B
Other Expenses 723 M
Net Income 3.16 B
RATIOS
63.70% GROSS MARGIN
63.70%
18.97% OPERATING MARGIN
18.97%
15.44% NET MARGIN
15.44%
17.02% ROE
17.02%
7.93% ROA
7.93%
10.61% ROIC
10.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Stryker Corporation
image
Net Income 3.16 B
Depreciation & Amortization 1.03 B
Capital Expenditures -575 M
Stock-Based Compensation 205 M
Change in Working Capital -500 M
Others 414 M
Free Cash Flow 3.14 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Stryker Corporation
image
Wall Street analysts predict an average 1-year price target for SYK of $382 , with forecasts ranging from a low of $345 to a high of $420 .
SYK Lowest Price Target Wall Street Target
345 USD -11.56%
SYK Average Price Target Wall Street Target
382 USD -2.14%
SYK Highest Price Target Wall Street Target
420 USD 7.67%
4. DIVIDEND ANALYSIS
0.22% DIVIDEND YIELD
0.8 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Stryker Corporation
image
Sold
0-3 MONTHS
109 M USD 4
3-6 MONTHS
68.8 M USD 3
6-9 MONTHS
6.03 M USD 2
9-12 MONTHS
122 M USD 6
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 07, 2024
Sell 6.72 M USD
Lobo Kevin
Chair and CEO
- 18269
367.95 USD
1 week ago
Nov 07, 2024
Sell 8.54 M USD
Lobo Kevin
Chair and CEO
- 23178
368.58 USD
1 week ago
Nov 07, 2024
Sell 5.87 M USD
Lobo Kevin
Chair and CEO
- 15866
369.75 USD
1 week ago
Nov 05, 2024
Sell 3.37 M USD
STRYKER RONDA E
director, 10 percent owner:
- 9254
363.65 USD
1 week ago
Nov 05, 2024
Sell 10.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 28832
364.58 USD
1 week ago
Nov 05, 2024
Sell 3.94 M USD
STRYKER RONDA E
director, 10 percent owner:
- 10774
365.53 USD
1 week ago
Nov 05, 2024
Sell 11.8 M USD
STRYKER RONDA E
director, 10 percent owner:
- 32085
366.57 USD
1 week ago
Nov 05, 2024
Sell 18 M USD
STRYKER RONDA E
director, 10 percent owner:
- 49028
367.6 USD
1 week ago
Nov 05, 2024
Sell 22 M USD
STRYKER RONDA E
director, 10 percent owner:
- 59652
368.5 USD
1 week ago
Nov 05, 2024
Sell 14.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 39211
369.37 USD
1 week ago
Nov 05, 2024
Sell 431 K USD
STRYKER RONDA E
director, 10 percent owner:
- 1164
370.07 USD
2 months ago
Sep 17, 2024
Sell 93.2 K USD
Fink M Kathryn
VP, Chief HR Officer
- 258
361.2067 USD
2 months ago
Sep 17, 2024
Sell 484 K USD
Fink M Kathryn
VP, Chief HR Officer
- 1336
362.2344 USD
2 months ago
Sep 17, 2024
Sell 172 K USD
Fink M Kathryn
VP, Chief HR Officer
- 474
363.2787 USD
2 months ago
Sep 17, 2024
Sell 232 K USD
Fink M Kathryn
VP, Chief HR Officer
- 635
364.5674 USD
2 months ago
Sep 17, 2024
Sell 178 K USD
Fink M Kathryn
VP, Chief HR Officer
- 487
365.3066 USD
2 months ago
Sep 17, 2024
Sell 342 K USD
Fink M Kathryn
VP, Chief HR Officer
- 931
367.1555 USD
2 months ago
Sep 17, 2024
Sell 169 K USD
Fink M Kathryn
VP, Chief HR Officer
- 460
367.9756 USD
2 months ago
Sep 17, 2024
Sell 251 K USD
Fink M Kathryn
VP, Chief HR Officer
- 680
369.052 USD
2 months ago
Sep 17, 2024
Sell 49.7 K USD
Fink M Kathryn
VP, Chief HR Officer
- 134
370.6365 USD
2 months ago
Sep 17, 2024
Sell 569 K USD
Fink M Kathryn
VP, Chief HR Officer
- 1530
371.5802 USD
2 months ago
Sep 13, 2024
Sell 785 K USD
Fink M Kathryn
VP, Chief HR Officer
- 2121
370 USD
2 months ago
Sep 17, 2024
Sell 157 K USD
Fink M Kathryn
VP, Chief HR Officer
- 422
372.5642 USD
2 months ago
Aug 27, 2024
Sell 213 K USD
Menon Viju
Group President
- 600
355 USD
3 months ago
Aug 06, 2024
Sell 672 K USD
STRYKER RONDA E
director, 10 percent owner:
- 2121
316.95 USD
3 months ago
Aug 06, 2024
Sell 978 K USD
STRYKER RONDA E
director, 10 percent owner:
- 3079
317.69 USD
3 months ago
Aug 06, 2024
Sell 1.15 M USD
STRYKER RONDA E
director, 10 percent owner:
- 3594
319.56 USD
3 months ago
Aug 06, 2024
Sell 1.95 M USD
STRYKER RONDA E
director, 10 percent owner:
- 6084
320.47 USD
3 months ago
Aug 06, 2024
Sell 1.27 M USD
STRYKER RONDA E
director, 10 percent owner:
- 3944
321.43 USD
3 months ago
Aug 06, 2024
Sell 15.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 48098
322.64 USD
3 months ago
Aug 06, 2024
Sell 13.4 M USD
STRYKER RONDA E
director, 10 percent owner:
- 41519
323.52 USD
3 months ago
Aug 06, 2024
Sell 19 M USD
STRYKER RONDA E
director, 10 percent owner:
- 58631
324.48 USD
3 months ago
Aug 06, 2024
Sell 5.83 M USD
STRYKER RONDA E
director, 10 percent owner:
- 17927
325.45 USD
3 months ago
Aug 06, 2024
Sell 1.63 M USD
STRYKER RONDA E
director, 10 percent owner:
- 5003
326.06 USD
3 months ago
Aug 02, 2024
Sell 6.66 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 20000
333 USD
5 months ago
May 22, 2024
Sell 668 K USD
Fletcher Robert S
VP, Chief Legal Officer
- 2007
332.9885 USD
6 months ago
May 15, 2024
Sell 3.28 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 10000
327.6516 USD
8 months ago
Mar 07, 2024
Sell 2.76 M USD
Berry William E Jr
VP, Chief Accounting Officer
- 7690
358.4824 USD
9 months ago
Feb 09, 2024
Sell 3.29 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 9600
342.8075 USD
9 months ago
Feb 05, 2024
Sell 10.6 M USD
STRYKER RONDA E
director, 10 percent owner:
- 31071
341.45 USD
9 months ago
Feb 05, 2024
Sell 23.9 M USD
STRYKER RONDA E
director, 10 percent owner:
- 69691
342.37 USD
9 months ago
Feb 05, 2024
Sell 21.9 M USD
STRYKER RONDA E
director, 10 percent owner:
- 63777
343.05 USD
9 months ago
Feb 05, 2024
Sell 6.46 M USD
STRYKER RONDA E
director, 10 percent owner:
- 18748
344.33 USD
9 months ago
Feb 05, 2024
Sell 5.48 M USD
STRYKER RONDA E
director, 10 percent owner:
- 15853
345.41 USD
9 months ago
Feb 05, 2024
Sell 694 K USD
STRYKER RONDA E
director, 10 percent owner:
- 2006
346 USD
9 months ago
Feb 06, 2024
Sell 18.6 M USD
STRYKER RONDA E
director, 10 percent owner:
- 54696
339.47 USD
9 months ago
Feb 06, 2024
Sell 10.1 M USD
STRYKER RONDA E
director, 10 percent owner:
- 29626
340.28 USD
9 months ago
Feb 06, 2024
Sell 1.78 M USD
STRYKER RONDA E
director, 10 percent owner:
- 5208
341.18 USD
9 months ago
Feb 06, 2024
Sell 194 K USD
STRYKER RONDA E
director, 10 percent owner:
- 566
341.97 USD
9 months ago
Feb 06, 2024
Sell 343 K USD
STRYKER RONDA E
director, 10 percent owner:
- 1000
343.45 USD
9 months ago
Feb 06, 2024
Sell 413 K USD
STRYKER RONDA E
director, 10 percent owner:
- 1200
344.47 USD
9 months ago
Feb 02, 2024
Sell 1.12 M USD
Golston Allan C.
Director
- 3273
341 USD
11 months ago
Dec 01, 2023
Sell 149 K USD
Datar Srikant M.
Director
- 500
298.223 USD
11 months ago
Nov 28, 2023
Sell 167 K USD
Berry William E Jr
VP, Chief Accounting Officer
- 573
292.2805 USD
1 year ago
Nov 17, 2023
Sell 9.44 M USD
Lobo Kevin
Chair and CEO
- 32857
287.4186 USD
1 year ago
Nov 17, 2023
Sell 4.35 M USD
Lobo Kevin
Chair and CEO
- 15092
288.2592 USD
1 year ago
Nov 17, 2023
Sell 2.33 M USD
Lobo Kevin
Chair and CEO
- 8060
289.1172 USD
1 year ago
Nov 17, 2023
Sell 137 K USD
Lobo Kevin
Chair and CEO
- 474
289.8863 USD
1 year ago
Nov 14, 2023
Sell 216 K USD
Datar Srikant M.
Director
- 750
287.5747 USD
1 year ago
Nov 15, 2023
Sell 144 K USD
Datar Srikant M.
Director
- 500
287.502 USD
1 year ago
Nov 16, 2023
Sell 146 K USD
Datar Srikant M.
Director
- 500
291.9245 USD
1 year ago
Sep 06, 2023
Sell 1.44 M USD
Menon Viju
Group President
- 5000
289 USD
1 year ago
Aug 10, 2023
Sell 215 K USD
Datar Srikant M.
Director
- 750
286.2279 USD
1 year ago
Jun 01, 2023
Sell 139 K USD
Datar Srikant M.
Director
- 500
278.5 USD
1 year ago
May 18, 2023
Sell 286 K USD
Datar Srikant M.
Director
- 1000
286 USD
1 year ago
Feb 28, 2023
Sell 1.44 M USD
Golston Allan C.
Director
- 5459
263.268 USD
1 year ago
Feb 09, 2023
Sell 571 K USD
Menon Viju
Group President
- 2161
264.3065 USD
1 year ago
Feb 06, 2023
Sell 20.9 M USD
STRYKER RONDA E
director, 10 percent owner:
- 77177
271.195 USD
1 year ago
Feb 06, 2023
Sell 9.35 M USD
STRYKER RONDA E
director, 10 percent owner:
- 34333
272.2124 USD
1 year ago
Feb 06, 2023
Sell 17.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 64143
273.3135 USD
1 year ago
Feb 06, 2023
Sell 6.31 M USD
STRYKER RONDA E
director, 10 percent owner:
- 23008
274.1307 USD
1 year ago
Feb 06, 2023
Sell 10.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 37977
275.3188 USD
1 year ago
Feb 06, 2023
Sell 8.23 M USD
STRYKER RONDA E
director, 10 percent owner:
- 29808
276.0452 USD
1 year ago
Feb 06, 2023
Sell 5.86 M USD
STRYKER RONDA E
director, 10 percent owner:
- 21154
277.1136 USD
1 year ago
Feb 06, 2023
Sell 2.23 M USD
STRYKER RONDA E
director, 10 percent owner:
- 8000
278.179 USD
1 year ago
Feb 06, 2023
Sell 956 K USD
STRYKER RONDA E
director, 10 percent owner:
- 3420
279.5052 USD
1 year ago
Feb 06, 2023
Sell 2.47 M USD
STRYKER RONDA E
director, 10 percent owner:
- 8780
280.9715 USD
1 year ago
Feb 07, 2023
Sell 5.98 M USD
STRYKER RONDA E
director, 10 percent owner:
- 22263
268.532 USD
1 year ago
Feb 07, 2023
Sell 4.83 M USD
STRYKER RONDA E
director, 10 percent owner:
- 17930
269.3086 USD
1 year ago
Feb 07, 2023
Sell 15.5 M USD
STRYKER RONDA E
director, 10 percent owner:
- 57331
270.5442 USD
1 year ago
Feb 07, 2023
Sell 6.29 M USD
STRYKER RONDA E
director, 10 percent owner:
- 23196
271.2727 USD
1 year ago
Feb 07, 2023
Sell 19.2 M USD
STRYKER RONDA E
director, 10 percent owner:
- 70648
272.4302 USD
1 year ago
Feb 07, 2023
Sell 5.69 M USD
STRYKER RONDA E
director, 10 percent owner:
- 20832
273.3705 USD
1 year ago
Feb 02, 2023
Sell 111 K USD
Pierce James Andrew
Group President
- 400
277.88 USD
1 year ago
Feb 03, 2023
Sell 851 K USD
Fletcher Robert S
VP, Chief Legal Officer
- 3000
283.5368 USD
1 year ago
Feb 02, 2023
Sell 2.14 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 7709
277.5544 USD
1 year ago
Feb 02, 2023
Sell 2.15 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 7708
278.3764 USD
1 year ago
Feb 02, 2023
Sell 2.48 M USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 8883
279.5191 USD
1 year ago
Feb 02, 2023
Sell 35 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 125
279.962 USD
1 year ago
Feb 02, 2023
Sell 924 K USD
Berry William E Jr
VP, Chief Accounting Officer
- 3303
279.7457 USD
1 year ago
Feb 02, 2023
Sell 211 K USD
Berry William E Jr
VP, Chief Accounting Officer
- 755
279.96 USD
1 year ago
Jan 11, 2023
Sell 297 K USD
Fink M Kathryn
VP, Chief HR Officer
- 1158
256.4898 USD
1 year ago
Jan 11, 2023
Sell 879 K USD
Fink M Kathryn
VP, Chief HR Officer
- 3417
257.3019 USD
1 year ago
Jan 11, 2023
Sell 363 K USD
Fink M Kathryn
VP, Chief HR Officer
- 1403
258.4492 USD
1 year ago
Jan 11, 2023
Sell 89.8 K USD
Fink M Kathryn
VP, Chief HR Officer
- 346
259.4873 USD
1 year ago
Jan 11, 2023
Sell 30.3 K USD
Fink M Kathryn
VP, Chief HR Officer
- 116
261.1212 USD
1 year ago
Jan 11, 2023
Sell 34.4 K USD
Fink M Kathryn
VP, Chief HR Officer
- 131
262.7188 USD
1 year ago
Dec 05, 2022
Sell 119 K USD
Datar Srikant M.
Director
- 500
238.6962 USD
1 year ago
Dec 07, 2022
Sell 240 K USD
Datar Srikant M.
Director
- 1000
240.255 USD
1 year ago
Dec 02, 2022
Sell 10.5 M USD
Lobo Kevin
Chair and CEO
- 43809
239.4264 USD
1 year ago
Dec 02, 2022
Sell 5.63 M USD
Lobo Kevin
Chair and CEO
- 23423
240.16 USD
2 years ago
Nov 07, 2022
Sell 63.7 K USD
Datar Srikant M.
Director
- 300
212.3573 USD
2 years ago
Nov 02, 2022
Sell 130 K USD
Datar Srikant M.
Director
- 600
216.71 USD
2 years ago
Nov 02, 2022
Sell 74.7 K USD
Fink M Kathryn
VP, Chief HR Officer
- 340
219.68 USD
2 years ago
Dec 10, 2021
Sell 116 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 447
258.9814 USD
2 years ago
Dec 10, 2021
Sell 456 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 1757
259.6759 USD
2 years ago
Dec 10, 2021
Sell 150 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 574
260.7839 USD
3 years ago
Nov 11, 2021
Sell 263 K USD
Datar Srikant M.
Director
- 1000
263.121 USD
3 years ago
Aug 06, 2021
Sell 39.3 M USD
STRYKER RONDA E
Director
- 150000
262.2606 USD
3 years ago
Aug 05, 2021
Sell 292 K USD
Fletcher Robert S
VP, Chief Legal Officer
- 1120
261.104 USD
3 years ago
May 04, 2021
Sell 27.6 M USD
Lobo Kevin
Chair and CEO
- 107795
255.7924 USD
3 years ago
Apr 30, 2021
Sell 1.31 M USD
Berry William E Jr
VP, Corporate Controller
- 5011
261.2764 USD
3 years ago
Apr 08, 2021
Sell 1 M USD
Fink M Kathryn
VP, Chief HR Officer
- 4000
250 USD
3 years ago
Mar 01, 2021
Sell 492 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 2000
246.014 USD
3 years ago
Dec 28, 2020
Sell 478 K USD
Boehnlein Glenn S
VP, Chief Financial Officer
- 2000
239.1045 USD
3 years ago
Dec 07, 2020
Sell 2.53 M USD
Lobo Kevin
Chairman and CEO
- 10697
236.2844 USD
3 years ago
Nov 23, 2020
Sell 1.16 M USD
Scannell Timothy J
President and COO
- 5000
232.6076 USD
4 years ago
Nov 13, 2020
Sell 296 K USD
Berry William E Jr
VP, Corporate Controller
- 1275
231.8405 USD
4 years ago
Aug 06, 2020
Sell 18.6 M USD
STRYKER RONDA E
Director
- 100000
185.9747 USD
4 years ago
Aug 06, 2020
Sell 7.46 M USD
STRYKER RONDA E
Director
- 40000
186.5493 USD
4 years ago
Jul 31, 2020
Bought 10.2 K USD
Doliveux Roch
Director
+ 53
191.94 USD
4 years ago
Jul 31, 2020
Sell 4.93 M USD
Lobo Kevin
Chairman and CEO
- 25855
190.7966 USD
7. News
SYK Stock Rises Following the Launch of Next Generation SurgiCount+ Stryker launches the next generation of SurgiCount+ to boost sponge management and blood loss assessment in hospitals. zacks.com - 1 day ago
Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio. prnewswire.com - 2 days ago
PBH vs. SYK: Which Stock Is the Better Value Option? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors? zacks.com - 5 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com - 1 week ago
Stryker Stock Gains on Q3 Earnings Beat & Raised Guidance SYK's third-quarter results reflect strong segmental performance, along with a rise in operating margin. zacks.com - 2 weeks ago
Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript Stryker Corporation. (NYSE:SYK ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - Citi Ryan Zimmerman - BTIG Travis Steed - Bank of America Matthew O'Brien - Piper Sandler Companies Vijay Kumar - Evercore ISI Matthew Miksic - Barclays Steven Litchman - Oppenheimer & Co David Roman - Goldman Sachs Christopher Pasquale - Nephron Research Jason Wittes - Roth MKM Michael Matson - Needham & Company Danielle Antalffy - UBS Equities Richard Newitter - Truist Securities Matthew Taylor - Jefferies Jeffrey Johnson - Robert W. seekingalpha.com - 2 weeks ago
Here's What Key Metrics Tell Us About Stryker (SYK) Q3 Earnings Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 weeks ago
Stryker (SYK) Surpasses Q3 Earnings and Revenue Estimates Stryker (SYK) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.78 per share. This compares to earnings of $2.46 per share a year ago. zacks.com - 2 weeks ago
Strong Segmental Performance to Drive Stryker's Q3 Earnings SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins. zacks.com - 3 weeks ago
Insights Into Stryker (SYK) Q3: Wall Street Projections for Key Metrics Evaluate the expected performance of Stryker (SYK) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com - 3 weeks ago
PBH or SYK: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 3 weeks ago
Stryker: A High Quality MedTech Name Investors Should Own Stryker Corporation is a global leader in medical devices, with strong growth prospects driven by an aging population and technological advancements. SYK has a robust track record of double-digit earnings growth and high single-digit organic revenue growth, outperforming peers. Stryker's innovative products, like the Mako robot, and strategic acquisitions bolster its market position and future growth potential. seekingalpha.com - 1 month ago
8. Profile Summary

Stryker Corporation SYK

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 149 B
Dividend Yield 0.22%
Description Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Contact 2825 Airview Boulevard, Kalamazoo, MI, 49002 https://www.stryker.com
IPO Date March 17, 1980
Employees 52000
Officers Mr. Jason Beach Vice President of Finance & Investor Relations Mr. Robert S. Fletcher Vice President & Chief Legal Officer Ms. Dana S. McMahon Vice President & Chief Compliance Officer Mr. Kevin A. Lobo Chairman, Chief Executive Officer & President Mr. Viju S. Menon Group President of Global Quality & Operations Mr. Robert C. Cohen Chief Technology Officer and Vice President of Global R&D - Joint Replacement Mr. Spencer S. Stiles Group President of Orthopaedics & Spine Mr. Alan Douville Vice President, Chief Information Officer & Chief Information Security Officer Mr. William E. Berry Jr. Vice President & Chief Accounting Officer Mr. J. Andrew Pierce Group President of MedSurg & Neurotechnology